“I am impressed by advanced technology of Indar’s manufacturing. It has to be shown not only to those who are involved in pharmaceutical industry, but also to everyone who wants to have modern production, because here, practically for the first time ever in our country, the GMP standards are adopted – the standards of the best manufacturing. This is a great illustration of Ukrainian biotechnological possibilities…” Borys Paton President of the National Academy of Sciences of Ukraine
PrJSC “Indar” today
- The enterprise with full technological cycle of genetically engineered insulin – from API to finished dosage forms
- Over 20 years of R&D and experience in medication manufacturing
- Full range of human recombinant insulin products manufactured based on proprietary technology
-
- Quality of the products is trusted by the patients and partners from Ukraine, Moldova, Kazakhstan, Russian Federation, Federative Republic of Brasília and other countries
- Proximate strategic development envisages product portfolio enhancement with immunoprophylaxis products (vaccines) as well as innovative drugs and medical devices that meet all needs of people living with Diabetes, HIV/ AIDS and Tuberculosis
- High quality of products, confirmed by years of use, fundamental R&D and innovative manufacturing technologies enabled PrJSC “Indar” to become the national leader in supporting the patients with Diabetes and other socially significant diseases.